drugset / Trial / NCT02656472

A Pilot Study Comparing Anti-Inflammatory Effects Of TXA Versus EACA In Pediatric Congenital Heart Surgery

NCT02656472

Phase 4 Completed 22 enrolled Wake Forest University Health Sciences
RandomizedParallel-groupQuadruple-blindOther

Summary

The purpose of this study is to compare anti-inflammatory effects of two anti-fibrinolytic drugs (Tranexamic acid versus Epsilon-aminocaproic acid) in pediatric patients undergoing pediatric cardiac surgery.

Timeline

Start
2016-02
Primary completion
2017-04
Completion
2017-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aminocaproic Acid Small molecule 75 mg/kg
Comparator Tranexamic Acid Small molecule 31 mg/kg

Indications

No indication recorded.